Kinnate Biopharma Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kinnate Biopharma Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2023.
  • Kinnate Biopharma Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $300K.
  • Kinnate Biopharma Inc. annual Operating Lease, Payments for 2023 was $1.2M, a 100% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $300K +$300K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.